drugset / Trial / NCT00546455
A Randomized, Double-blind Study of the Effects of Fenretinide Administered in Subjects With Obesity
RandomizedParallel-groupTriple-blindTreatment
Summary
Many metabolic complications of obesity are a consequence of abnormal responses of the liver, muscle, and fat to insulin actions. Fenretinide may improve the effects of insulin, preventing metabolic complications.
Timeline
- Start
- 2007-12
- Primary completion
- 2012-01
- Completion
- 2099-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | fenretinide | Small molecule | 200 mg | — |